June 13 (Bloomberg) -- Ranbaxy Laboratories Ltd., India's biggest drugmaker, rose to its highest price in more than three years after the Business Standard reported that Pfizer Inc. may try to top Daiichi Sankyo Co.'s takeover bid.
Pfizer, the world's largest drugmaker, may make a hostile bid for the 65 percent of Ranbaxy that isn't held by the founding Singh family, the Standard said today. Neither Pfizer nor Daiichi would comment. A spokesman for Ranbaxy said the agreement with Daiichi Sankyo, announced June 11, ``is sealed.''
The whole story can be read here.
No comments:
Post a Comment